Myh6-driven Cre recombinase activates the DNA damage response and the cell cycle in the myocardium in the absence of loxP sites
Regeneration of muscle in the damaged myocardium is a major objective of cardiovascular research, for which purpose many investigators utilize mice containing transgenes encoding Cre recombinase to recombine loxP-flanked target genes. An unfortunate side effect of the Cre-loxP model is the propensit...
Saved in:
Main Authors: | Xinrui Wang (Author), Amelia Lauth (Author), Tina C. Wan (Author), John W. Lough (Author), John A. Auchampach (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cre-LoxP and tamoxifen-induced deletion of ovarian quiescin sulfhydryl oxidase 2 showed disruption of ovulatory activity in mice
by: Shih-Yun Chen, et al.
Published: (2024) -
In vivo dynamics of hard tissue-forming cell origins: Insights from Cre/loxP-based cell lineage tracing studies
by: Toshihide Mizoguchi
Published: (2024) -
Tetracycline response element driven Cre causes ectopic recombinase activity independent of transactivator element
by: Kenneth T. Lewis, et al.
Published: (2022) -
Cre-Recombinase Induces Apoptosis and Cell Death in Enterocyte Organoids
by: Franziska Moll, et al.
Published: (2022) -
CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool
by: Fayu Yang, et al.
Published: (2017)